Global Point-of-Care (POC) Coagulation Testing Market – Industry Trends and Forecast to 2030

Global Point-of-Care (POC) Coagulation Testing Market, By End-User (Hospitals and Clinics, Home care), Technology (Optical Technology, Mechanical Technology, Electrochemical Technology), Distribution Channel (Direct Tenders, Retail) – Industry Trends and Forecast to 2030.

Point-of-Care (POC) Coagulation Testing Market Analysis and Size

Point-of-Care coagulation testing are used to determine how long it takes for clot formation to begin, the dynamics of clot formation, and the solidity and stability of clots over time. They allow for parallel measurements on a single blood sample after clotting is activated with a variety of agonists.                               

Data Bridge Market Research analyzes that the global  Point-of-Care (POC) Coagulation Testing market, which was USD 1128.87 million in 2022, is likely to reach USD 1618.93 million by 2030, and is expected to undergo a CAGR of 4.61% during the forecast period. “Optical technology” segment of the technology segment is dominating the market owing to the advancements in technology. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Point-of-care coagulation testing (POCCT) allows clinicians to quickly assess a patient's coagulation status in real time. POCCT has several advantages over standard coagulation assays. As a result, there is growing interest in using POCCT in a wide range of clinical settings, including trauma, cardiac surgery, obstetrics, liver disease, and burns. POC coagulation testing allows for rapid clinical decisions in haematological interventions and, when used in conjunction with a proper transfusion algorithm, may reduce blood product usage and potentially complications associated with blood transfusion.

Point-of-Care (POC) Coagulation Testing Market Dynamics

Drivers

• Significant consumption of anticoagulant drugs

Anticoagulant drugs, also known as blood thinners which helps to reduce the chances of atrial fibrillation-related heart strokes about 75%. The growing consumption of these drugs is driving the need for coagulation testing procedures to monitor blood clotting. This demand will lead to the expansion of the point-of-care (POC) coagulation testing market during the forecast period.

• Automation in POC coagulation testing products

The growth of automated POC coagulation testing products is growing due to surging demand, automatic data uploading, and minimal human efforts. This has helped medical practitioners to perform rapid testing with minimal intervention. The automation in POC coagulation testing products is expected to have a positive impact on the overall market growth.

Opportunity

• Rising incidence of cardiovascular diseases

Rising incidence of cardiovascular illnesses and blood disorders is likely to have a substantial impact on the point-of-care (POC) coagulation testing market in the forecast period.  Though genetic factors can increase your chances of developing heart disease, unhealthy lifestyle choices also play a significant role. Sedentary lifestyles and a lack of physical activity are two unhealthy lifestyle choices that can contribute to heart disease.

Restraint/Challenge

• High cost of POC analyzers

However, high cost of POC analyzers and reagents in coagulation testing, stringent government regulation on POC coagulation testing products, precision and concerns related to variability in accuracy may hamper the growth of the POC coagulation testing industry over the forecast period will obstruct the market's growth rate.

This point-of-care (POC) coagulation testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point-of-care (POC) coagulation testing market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In January 2022, Roche introduced its Cobas Pulse System in select countries accepting the CE Mark. This is the latest generation of linked point-of-care solutions for professional blood glucose management from Roche Diagnostics
• In March 2021, Thermo Fisher Scientific, an American manufacturer and supplier of scientific instrumentation, reagents and consumables, and software devices, announced its collaboration with Artificial Inc., a leading developer of flexible automation software. With this collaboration, the companies aimed to develop an integrated and comprehensive software automation platform for Covid-19 testing to reduce the spread of the disease and restore economies and communities

Global Point-of-Care (POC) Coagulation Testing Market Scope

The point-of-care (POC) coagulation testing market is segmented on the basis of end-user, technology and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

End-User

• Hospitals
• Clinics
• Home care

 Technology

• Optical Technology
• Mechanical Technology
• Electrochemical Technology

Distribution Channel

• Direct Tenders
• Retail

Point-of-Care (POC) Coagulation Testing Market Regional Analysis/Insights

The point-of-care (POC) coagulation testing market is analysed and market size insights and trends are provided by country, end-user, technology and distribution channel as referenced above.

The countries covered in the Point-of-Care (POC) Coagulation Testing  Market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific , Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.

North America is expected to dominate the point-of-care (POC) coagulation testing market due to the surging levels of investment for the development of the healthcare industry along with growth of new technologies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period due to the increasing healthcare expenditure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The point-of-care (POC) coagulation testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Point-of-Care (POC) Coagulation Testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Point-of-Care (POC) Coagulation Testing market. The data is available for historic period 2010-2020.

Competitive Landscape and Point-of-Care (POC) Coagulation Testing Market Share Analysis

The point-of-care (POC) coagulation testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Point-of-Care (POC) Coagulation Testing market.

Some of the major players operating in the point-of-care (POC) coagulation testing market are:

• Abbott (U.S.)
• Danaher (U.S.)
• Siemens (Germany)
• Sysmex Corporation (U.S.)
• Thermo Fisher Scientific Inc.  (U.S.)
• Horiba Ltd.  (Japan)
• Nihon Kohden Corporation (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Maccura Biotechnology Co. Ltd. (China)
• Bio Group Medical System (Italy)
• Genrui Biotech Co. Ltd. (China)
• A&T Corporation (Japan)
• Beijing Succeeder Technology Inc. (China)
• Diagnostica Stago SAS (France)
• Helena Laboratories Corporation (U.S.)
• Hycel (Austria)